Clinical Trial Update: Pharmacogenomics of Antiplatelet Response - I [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Johns Hopkins on pharmacogenomics of antiplatelet response, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Johns Hopkins University | Conditions: Platelet Aggregation, Platelet Transcriptome | Phase 4 | Status: COMPLETED | Results posted: 2017-01-09